Melbourne, Jan 10, 2008 (ABN Newswire) - The Directors of Solagran Limited (ASX: SLA)(PNK: SOGRF) are pleased to announce that the Russian Agency for Patents and Trademarks has accepted a patent application submitted by Solagran covering the use of Bioeffective(r) A in the treatment of Helicobacter pylori infection. If awarded, the priority date for this patent will be 26 December, 2007.
